View by type:
Articles (4214)
What are nucleic acid vaccines and how could they be used against COVID-19?
Nucleic acid vaccines use genetic material from a disease-causing virus to trigger protective immunity against it.
Rethinking healthcare in Africa with geospatial mapping
In August 2020, Nigeria became the last African country to be declared free from wild poliovirus.
Five mantras for effective COVID-19 vaccine communication
Well-designed communication can increase healthy behaviours, including vaccine uptake. Here are our top five mantras for how to think about COVID-19 vaccine communication.
MVIP update – 1 million doses administered, Kenya 1st anniversary, cooperation for vaccine access
Kenya marked its 1st anniversary of the launch of the pilot in September, with more than 128,000 children reached with vaccine, and one country health official expressing “a great sense of pride” in being part of the effort to protect children…
What you need to know about COVID-19 vaccine approvals in Nigeria and South Africa
Before any COVID-19 vaccines can be delivered to the public, their use must be approved by national regulatory authorities. We look into the process before vaccines would be approved for distribution and use in Nigeria and South Africa.
A united front: building vaccine confidence during a pandemic
To combat vaccine misinformation at home and around the globe, we must build trust.
What to expect when you get a COVID-19 vaccine
Now that the first COVID-19 vaccine has been approved, and others are on the way, what does getting vaccinated actually involve? Here are some of the logistics involved and what to expect after you’ve had your vaccine.
There are four types of COVID-19 vaccines: here’s how they work
The fight against COVID-19 has seen vaccine development move at record speed, with more than 170 different vaccines in trials. But how are they different from each other and how will they protect us against the disease?
Two billion doses of COVID-19 vaccines have been secured to ensure that no-one misses out
The COVAX Facility plans to start rolling out the doses in early 2021 to high-risk groups in participating countries, with the aim of vaccinating up to 20% of populations of participating countries by the end of the year.
To be effective, COVID-19 vaccination plans must include migrants
As we prepare for one of the world’s largest vaccination efforts, and on the occasion of International Migrants Day, we are coming to a critical reckoning: the need for inclusive approaches in our health-related thinking and practices has never…
There’s a new strain of COVID-19 – should we worry?
Viruses mutate all the time, but this new mutation affects the viral protein that invades human cells. What does this mean for the pandemic and the vaccine?
COVAX now has agreements in place to access nearly two billion doses of several promising vaccine candidates, and laid the groundwork for further doses to be secured through contributions from donors.
